Alecensa 150mg Capsule: Treatment for Advanced Non-Small Cell Lung Cancer

Alecensa 150mg Capsule

Active ingredient: Alectinib Hydrochloride.

Use:

• Treats ALK-positive Non-small cell lung cancer (NSCLC) that has spread to other organs, including the brain.

Therapeutic effects:

• Targets a specific genetic mutation called anaplastic lymphoma kinase (ALK) in NSCLC cells.
• Inhibits the ALK protein, slowing down or stopping the growth and spread of cancer cells with the ALK mutation.

Dosage and administration:

• Taken orally as a capsule with food.
• Swallowed whole with water, not to be crushed, chewed, or opened.
• Dosage and duration determined by a healthcare provider.
• If a dose is missed, take as soon as possible unless it is within 12 hours of the next dose; in that case, skip the missed dose.

Safety advice:

• Pregnancy: not safe during pregnancy.
• Breastfeeding: consult a healthcare provider before taking.
• Lungs: monitor lung function regularly.
• Liver: monitor liver function regularly, as Alecensa can cause liver damage.
• Alcohol: avoid alcohol consumption.
• Driving: avoid driving or operating machinery if experiencing side effects such as fatigue, dizziness, or blurred vision.

Interactions:

• Inform healthcare provider about all medications, including prescription, over-the-counter, supplements, and herbal products.
• Certain medications may interact with Alecensa and reduce effectiveness.

Storage:

• Store at room temperature between 68°F to 77°F (20°C to 25°C).
• Keep in the original container, away from light, moisture, and heat.
• Once opened, use the blister pack within 14 days.

Side effects:

• Serious: yellowing of skin, dark urine, pain at the right side of the stomach, skin itching, loss of appetite, nausea and vomiting, easy bleeding or bruising, persistent muscle pain, tender or weak muscles, loss of consciousness, dizziness, low blood pressure, difficulty breathing, cough, fever.
• Common: elevated liver enzymes, rashes, oedema, fatigue, diarrhoea, constipation, weight gain, inflammation in mouth, light sensitivity, changes in taste.

FAQ:

• Q1: What is ALK Positive lung cancer?
  • ALK positive lung cancer is a subset of lung cancer common in non-smokers aged less than 55 years. ALK is a protein that stands for anaplastic lymphoma Kinase, and mutation in this gene causes lung cancer cells to grow rapidly.
• Q2: Can Alecensa 150mg Capsule cause weight gain?
  • Weight gain is a potential side effect, although not very common.
• Q3: Can Alecensa 150mg Capsule cause mood changes or depression?
  • Mood changes and depression have been reported in some patients.
• Q4: Is Alecensa 150mg Capsule used in patients with brain metastases?
  • Alecensa has been shown to be effective in treating brain metastases in patients with ALK-positive NSCLC.
• Q5: Can I use Alecensa 150mg Capsule if I have kidney problems?
  • Alecensa may be used in patients with mild to moderate kidney problems without dosage adjustment. However, patients with severe kidney problems may need dosage adjustments or additional monitoring.

Fact box:

• Molecule name: Alectinib.
• Therapeutic class: Anticancer.
• Pharmacological class: Tyrosine kinase inhibitor.
• Indications: ALK-positive lung cancer (NSCLC).

Tags: cancer_treatment, alecensa_drug, anticancer_medicine, treatment_capsules, oncology_treatment, cancer_medication, drug_therapy, chemotherapy_alternative, targeted_therapy